Intensive dietary intervention and dietary intervention combined with an increase in moderate activity were both superior to usual care in a real-world comparison of diabetic patients in the first 6 months after being diagnosed.…
Read More »ADA: Insulin Pump Suspend Feature Halts Hypoglycemia
Insulin pumps that automatically shut down when blood glucose hits a certain low level decrease the amount of time pediatric patients spend in hypoglycemia….
Read More »ADA: Diabetes Patients Lead Peers to Healthier Status
Training people with diabetes to teach other patients improves utilization of medications and results in lifestyle changes….
Read More »ADA: Vascular Status Predicts Hypoglycemia
Type 2 diabetes patients with microvascular or macrovascular complications, or those taking certain monotherapies, are more likely to experience hypoglycemia and require outpatient hospital visits….
Read More »ADA: Even Diet Soda Induces Weight Gain in the Elderly
The perception that diet soft drinks are a benign alternative to highly sweetened beverages might be dangerously wrong….
Read More »ADA: Intensive Therapy Yields Negligible Benefits in Type 2 Diabetes
In patients diagnosed with type 2 diabetes through screening in general practice, intensive multifactorial treatment improved cardiovascular risk factors, compared with usual care, new findings suggest, but those improvements were very small.…
Read More »ADA: Higher Vitamin D Levels Linked to Lower Diabetes Risk
Higher levels of vitamin D in the blood appear to be associated with a reduced risk for incident diabetes among people at high risk for the disease.…
Read More »ADA: TAK-875 a Novel Agent in the Treatment of Type 2 Diabetes
Takeda Pharmaceuticals recently completed a Phase 2 study with its novel anti-diabetic agent TAK-875, which could help lead to more individualized patient care and diabetes management….
Read More »ADA: Restoring Visual Acuity in Diabetes with VEGF Inhibitor
The vascular endothelial growth factor (VEGF) inhibitor ranibizumab (Lucentis) proves promising in treating diabetic macular edema….
Read More »NC-stat — DPNCheck
NC-stat — DPNCheck Fast, accurate and quantitative test that may be used to evaluate peripheral neuropathies such as DPN. It may aid in the early detection, confirmation, and monitoring of DPN. It measures sural nerve conduction velocity – a standard biomarker for subclinical and symptomatic DPN. It is sensitive and specific for …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.